Picture EBD Group Biotech Showcase 2023 San Francisco 650x100px

News > All

Total search results: 6897 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 ... 67 68 69  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris. 2022-02-17
Heidelberg Pharma AG. (2/17/22). "Press Release: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini (ad hoc)". Ladenburg. 2022-02-17
ITM Isotope Technologies Munich SE. (2/16/22). "Press Release: ITM Receives Equity Investment of EUR 25 Million from Strategic Partner Grand Pharma". Garching & Hong Kong. 2022-02-16
Centauri Therapeutics Ltd.. (2/16/22). "Press Release: Centauri Therapeutics Closes £24 million GBP Series A Investment Round". London. 2022-02-16
SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona. 2022-02-16
Climedo Health GmbH. (2/16/22). "Press Release: Climedo Closes €5 Million Seed Financing Round". Munich. 2022-02-16
XO Life GmbH. (2/16/22). "Press Release: Two Million Euros for XO Life GmbH’s Patient Insights Platform". Berlin & Munich. 2022-02-16
Kerry Group plc. (2/15/22). "Press Release: Kerry Announces Significant Strategic Biotechnology Acquisitions". 2022-02-15
IMIdomics, Inc.. (2/15/22). "Press Release: IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE". San Rafael, CA & Barcelona. 2022-02-15
SHS Gesellschaft für Beteiligungsmanagement mbH. (2/15/22). "Press Release: SHS Sells Leading Enzyme Engineering Company c-LEcta GmbH to Kerry Group". Tübingen. 2022-02-15
NMD Pharma A/S. (2/15/22). "Press Release: NMD Pharma Raises €35 Million in a New Financing". Aarhus. 2022-02-15
c-LEcta GmbH. (2/15/22). "Press Release: c-LEcta Announces that it Has Reached Agreement to Be Acquired by Kerry Group". 2022-02-15
Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg. 2022-02-15
ProBioGen AG. (2/11/22). "Press Release: ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology". Berlin. 2022-02-11
Green Elephant Biotech GmbH. (2/11/22). "Press Release: Pre-seed Funding Round for Green Elephant Biotech. BMH Invests in Developer of Sustainable Cell Cultivation Systems". Wiesbaden & Gießen. 2022-02-11
Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA. 2022-02-10
Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA. 2022-02-09
Lindis Blood Care GmbH. (2/9/22). "Press Release: Lindis Blood Care Successfully Closes Follow-on Financing Round". Hennigsdorf. 2022-02-09
AiCuris Anti-infective Cures AG. (2/9/22). "Press Release: AiCuris and Hybridize Therapeutics Enter Worldwide License Agreement of up to €100M for a Direct-acting RNA-based Therapy against BK Virus". Wuppertal & Leiden. 2022-02-09
ECBF Management GmbH. (2/9/22). "Press Release: Insect Scale-up Protix Raises 50 Million for Expansion and Development from International Investors". Wuppertal & Leiden. 2022-02-09
Haya Therapeutics S.A.. (2/9/22). "Press Release: Haya Therapeutics Establishes U.S. Location. Haya Closes US$5M Seed Extension". Lausanne & San Diego, CA. 2022-02-09
Evolva Holding S.A.. (2/8/22). "Press Release: Evolva Appoints Christian Wichert as New CEO to Boost Growth Strategy and Enter Its Next Phase of Development and Commercialization". Reinach. 2022-02-08
BRAIN Biotech AG. (2/8/22). "Press Release: BRAIN Biotech and Formo. Strategic Partnership of European Biotech Experts for the Production of Animal-free Milk Protein". Zwingenberg. 2022-02-08
Inova Software S.A.S.. (2/8/22). "Press Release: Inova Acquires In-Part, Matchmaking Platform for Academia-Industry Collaboration". Lyon. 2022-02-08
AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA. 2022-02-07
Merck KGaA. (2/7/22). "Press Release: Merck Announces Organizational Transformation of Life Science Business Sector to Strengthen CDMO Offering and Accelerate Future Growth". Darmstadt. 2022-02-07
ECBF Management GmbH. (2/7/22). "Press Release: ECBF Invests in the €16M VC Round of Elicit Plant, France, to Accelerate Commercialization of Their Water Stress Management Solutions for Field Crops Internationally". Luxembourg. 2022-02-07
Bayer AG. (2/4/22). "Press Release: Bayer Will Discontinue Phase II Development Candidate eliapixant [only for specialized press]". Berlin. 2022-02-04
Evotec SE. (2/4/22). "Press Release: Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to All P2X3 Assets [Ad hoc release]". Hamburg. 2022-02-04
Nemis Technologies AG. (2/3/22). "Press Release: Nemis Technologies AG Closes a CHF 7.75 Million Series A Funding Round". Dübendorf. 2022-02-03
iOmx Therapeutics AG. (2/3/22). "Press Release: iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development". Martinsried. 2022-02-03
Bayer AG. (2/3/22). "Press Release: Bayer Appoints Christine Roth as New Head of Oncology Strategic Business Unit at Pharmaceuticals Division". Berlin. 2022-02-03
eTheRNA Immunotherapeutics N.V.. (2/3/22). "Press Release: eTheRNA Announces Research Agreement with Merck to Access mRNA technologies". Niel. 2022-02-03
Celeris Therapeutics GmbH. (2/2/22). "Press Release: Celeris Therapeutics, the PIC Engineering Company, Announces the Appointment of Biotech Veterans to Lead Drug Discovery and Biology Efforts". 2022-02-02
BRAIN Biotech AG. (2/2/22). "Press Release: AnalytiCon Discovery and Pharvaris Extend Their Collaboration". Potsdam. 2022-02-02
Centogene N.V.. (2/1/22). "Press Release: Centogene Announces Nomination of Kim Stratton as Chief Executive Officer". Cambridge, MA, Rostock & Berlin. 2022-02-01
HH2E AG. (2/1/22). "Press Release: HH2E, New Strong Player in the German Green Energy Sector. HH2E Plans Investments of €2.7 Billion (CAPEX) in Projects in Germany". 2022-02-01
Medix Biochemica Oy. (2/1/22). "Press Release: Medix Biochemica Expands Its Molecular Diagnostics Business through the Acquisition of myPOLS Biotec". Espoo. 2022-02-01
Ethris GmbH. (2/1/22). "Press Release: Ethris Raises $26.3 Million Series B to Advance Pipeline of mRNA-based Therapeutics for Respiratory Diseases". Munich. 2022-02-01
BRAIN Biotech AG. (2/1/22). "Press Release: BRAIN Group Significantly Expands Its Food Enzyme Business with the Acquisition of Breatec B.V. and Comix Business". Zwingenberg. 2022-02-01
Roche. (2/1/22). "Press Release: Changes to the Roche Board of Directors and the Corporate Executive Committee". Basel. 2022-02-01
Brainomix Ltd.. (2/1/22). "Press Release: Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-powered Radiomic Software for Automated Assessment of Solid Tumor Cancer". Oxford. 2022-02-01
Centogene N.V.. (2/1/22). "Press Release: Centogene Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan". Cambridge, MA, Rostock & Berlin. 2022-02-01
Zetta Genomics Ltd.. (2/1/22). "Press Release (News): Zetta Genomics Gains £2.5m Seed Funding to Realise the Power of Genomic Data in Precision Medicine". New York, NY. 2022-02-01
Temedica GmbH. (2/1/22). "Press Release: Temedica Partners with Noventi to Enhance Permea-generated Insights to Improve Patient Care". Munich. 2022-02-01
Glycotope GmbH. (2/1/22). "Press Release: Glycotope to Spin-out Its Service Business to the Newly Formed FyoniBio GmbH". Berlin. 2022-02-01
Glooko, Inc.. (1/31/22). "Press Release: Glooko Acquires Germany-Based xbird, a Medical AI Company". Berlin & Palo Alto, CA. 2022-01-31
Gandeeva Therapeutics, Inc.. (1/31/22). "Press Release: Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions". Vancouver, BC. 2022-01-31
Leo Pharma A/S. (1/31/22). "Press Release: Leo Pharma Appoints Christophe Bourdon as New CEO". Ballerup. 2022-01-31
Ribbon Biolabs GmbH. (1/31/22). "Press Release: Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology". Vienna. 2022-01-31
Mainz Biomed N.V.. (1/28/22). "Press Release: Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares". Berkeley, CA & Mainz. 2022-01-28
Mainz Biomed N.V.. (1/27/22). "Press Release: Mainz Biomed Appoints Steve Quinn as VP Business Development". Berkeley & Mainz. 2022-01-27
Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development". 2022-01-26
genOway S.A.. (1/25/22). "Press Release: genOway Grants the Leading UK Academic Research Funder a Non-exclusive License for CRISPR/Cas9 Technology". Lyon. 2022-01-25
Cytovation AS. (1/25/22). "Press Release: Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy". Bergen. 2022-01-25
Metagenomi Inc.. (1/25/22). "Press Release: Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform". Emeryville, CA. 2022-01-25
InstaDeep. (1/25/22). "Press Release: InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems". London. 2022-01-25
Evotec SE. (1/25/22). "Press Release: Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology". Hamburg. 2022-01-25
Cellino Biotech, Inc.. (1/25/22). "Press Release: Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing". Cambridge, MA & Leverkusen. 2022-01-25
Cyprumed GmbH. (1/24/22). "Press Release: Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics". Innsbruck. 2022-01-24
Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg. 2022-01-21
Lift BioSciences Ltd.. (1/21/22). "Press Release: Lift BioSciences Secures Its Largest Financing to Date with a further £5m". London. 2022-01-21
Psyros Diagnostics Ltd.. (1/20/22). "Press Release: Psyros Diagnostics Ltd Acquired by Prolight Diagnostics AB". 2022-01-20
Centogene N.V.. (1/20/22). "Press Release: Centogene Joins Forces with Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development". Cambridge, MA, Rostock & Berlin 2022-01-20
EOS GmbH. (1/19/22). "Press Release: EOS Launches End-To-End Production Network". Krailing. 2022-01-19
Bruker Corporation. (1/19/22). "Press Release: Bruker Acquires Prolab Instruments to Augment Multiomics Solutions". Billerica, MA. 2022-01-19
PreOmics GmbH. (1/18/22). "Press Release: PreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and Consumables". Munich. 2022-01-18
ADC Therapeutics S.A.. (1/18/22). "Press Release: ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize Zynlonta(loncastuximab tesirine-lpyl) in Japan". Lausanne. 2022-01-18
Cytosurge AG. (1/18/22). "Press Release: R&D Project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology Receives Funding by Innosuisse". Zurich. 2022-01-18
TVM Capital Life Science. (1/18/22). "Press Release: TVM Capital Life Science Promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner". Munich & Montréal. 2022-01-18
Inova Software S.A.S.. (1/18/22). "Press Release: Inova Acquires Leading European Biotech News Media Company, Labiotech". Lyon. 2022-01-18
Indivumed GmbH. (1/17/22). "Press Release: Accelerated Drug Development and Personalised Treatments for Cancer. Indivumed Receives EU Funding from ERDF Structural Fund". Hamburg. 2022-01-17
Neurimmune AG. (1/17/22). "Press Release: Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases". Zürich. 2022-01-17
Wacker Chemie AG. (1/17/22). "Press Release: Plasmitec – Wacker Introduces Its Plasmid DNA Production Platform". Munich & San Diego, CA. 2022-01-17
Relief Therapeutics Holding AG. (1/14/22). "Press Release: Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed Lawsuit". Geneva. 2022-01-14
Merck KGaA. (1/13/22). "Press Release: Merck Announces New Appointments in Global R&D and Strategy Leadership for Healthcare Business Sector". Darmstadt. 2022-01-13
ITM Isotope Technologies Munich SE. (1/13/22). "Press Release: ITM and Helmholtz Munich Sign Cooperation Agreement for the Clinical Development of Radiopharmaceutical Therapy to Treat Glioblastoma Multiforme". Garching. 2022-01-13
Temedica GmbH. (1/12/22). "Press Release: Temedica Introduces Permea. First Analytics Platform Integrating Patient-Generated Health Data". Munich. 2022-01-12
ProtaGene GmbH. (1/12/22). "Press Release: Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene". Heilbronn, Heidelberg & Boston, MA. 2022-01-12
Relief Therapeutics Holding AG. (1/12/22). "Press Release: Relief Comments on Lawsuit Filed Against It by NeuroRx". Geneva. 2022-01-12
Pantherna Therapeutics GmbH. (1/11/22). "Press Release: Pantherna Therapeutics Secures EUR 4.0 Mio. Follow-on Financing to Advance Its Therapeutic mRNA Development Programs". Hennigsdorf. 2022-01-11
Wacker Chemie AG. (1/11/22). "Press Release: Wacker and Biosyntia Develop Large-Scale Production Process for Sustainable Biotin". Munich & Copenhagen. 2022-01-11
Creoptix AG. (1/11/22). "Press Release: Malvern Panalytical Expands Pharmaceutical Drug Development Solutions through the Acquisition of Creoptix". 2022-01-11
BioNTech SE. (1/11/22). "Press Release: BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants". Mainz & London. 2022-01-11
Molecular Partners AG. (1/10/22). "Press Release: Molecular Partners and Novartis Report Positive Topline Data from Phase 2 Study for Ensovibep (MP0420), a DARPin Antiviral Therapeutic for COVID-19". Zürich-Schlieren & Concord, MA. 2022-01-10
Mammoth Biosciences, Inc.. (1/10/22). "Press Release: Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology". Berlin & Brisbane, CA. 2022-01-10
BioNTech SE. (1/10/22). "Press Release: BioNTech and Crescendo Biologics Announce Global Collaboration to Develop Multi-specific Precision Immunotherapies". Mainz & Cambridge. 2022-01-10
Xlife Sciences AG. (1/10/22). "Press Release: Xlife Sciences Plans Listing on the »Sparks« Segment of SIX Swiss Exchange". Zürich. 2022-01-10
Electrochaea GmbH. (1/7/22). "Press Release: Growth-Stage Power-to-Gas Company Electrochaea Closes Series D Financing Round". Munich. 2022-01-07
Neurimmune AG. (1/7/22). "Press Release: Neurimmune Enters into a Collaboration and License Agreement with AstraZeneca to Develop and Commercialize NI006". Zürich. 2022-01-07
Merck KGaA. (1/6/22). "Press Release: Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA". Darmstadt. 2022-01-06
Novartis AG. (1/6/22). "Press Release: Novartis Announces Collaboration with Alnylam to Explore Targeted Therapy to Restore Liver Function". Basel. 2022-01-06
BioNTech SE. (1/5/22). "Press Release: Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine". New York, NY & Mainz. 2022-01-05
ITM Isotope Technologies Munich SE. (1/5/22). "Press Release: ITM Isotope Technologies Munich to Present at the 40th Annual J.P. Morgan Healthcare Conference". Garching. 2022-01-05
T-Knife Therapeutics, Inc.. (1/5/22). "Press Release: T-knife Therapeutics Appoints Ronald Krasnow, J.D., as General Counsel". South San Francisco, CA & Paris. 2022-01-05
Spectro Analytical Instruments GmbH. (1/4/22). "Press Release: Change in Spectro Management – Michael Privik Succeeds Dr. Christoph Mätzig". Kleve. 2022-01-04
Bruker Corporation. (1/4/22). "Press Release: Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference". Billerica, MA. 2022-01-04
Santhera Pharmaceuticals Holding AG. (1/4/22). "Press Release: Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare Diseases in the Greater China Region". Pratteln. 2022-01-04
Noxxon Pharma N.V.. (1/3/22). "Press Release: Noxxon Secures €17 Million Expansion of Equity-linked Facility with Atlas to Advance NOX-A12 in Glioblastoma and Pancreatic Cancer Programs [ corrected version of press release originally issued 29 Dec 2021 ] 2022-01-03
Evotec SE. (1/3/22). "Press Release: Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic". Hamburg. 2022-01-03
next pagenext page 1 2 3 4 5 6 ... 67 68 69  next pagenext page


Picture [iito] Fighting Customers 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x300px

» top